UR

Uma Rani Burra

Director Director DIN 06906594
DIN 06906594 First appointment Aug 2014 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Aug 2014
Shareholding value Locked Premium profile

About Uma Rani Burra

Data last updated:

Uma Rani Burra has 12 years in corporate governance. Formerly with 1 company, such as Averx Drugs Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 06906594
Primary Designation Director
First Appointment 26 Aug 2014
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Averx Drugs Private Limited U24100AP2014PTC095163
Managing Director26 Aug 20142014Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Averx Drugs Private Limited
Premium access

Shareholding and investment profile for Uma Rani Burra

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Uma Rani Burra

Uma Rani Burra has 12 years in corporate governance. Formerly with 1 company, such as Averx Drugs Private Limited. Engaged in General Business. Contributes to corporate operations.

Uma Rani Burra is associated with 0 companies as a director.

Uma Rani Burra has expertise in General Business.

Uma Rani Burra has 12 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available